Asbestos-related malignancy

Area of Science:

• Oncology
• Pathology
• Radiology

Background:

• Malignant mesothelioma is a rare cancer, disproportionately significant due to its association with asbestos exposure.
• The disease affects approximately 2.2 per million individuals in the American population.
• Clinical presentation commonly includes chest pain and dyspnea, with initial chest X-rays often showing large unilateral pleural effusions.

Purpose of the Study:

• To summarize the key aspects of malignant mesothelioma, including its presentation, diagnosis, and current treatment challenges.
• To highlight the diagnostic modalities and therapeutic outcomes for this asbestos-related malignancy.

Main Methods:

• Histologic diagnosis typically requires a substantial tissue sample obtained via open biopsy.
• Investigational diagnostic methods include multiple needle biopsies for electron microscopy and immunoperoxidase staining for keratin and CEA.
• Review of current treatment strategies and reported patient outcomes.

Main Results:

• Malignant mesothelioma characteristically remains localized until advanced stages.
• Treatment efficacy for mesothelioma is currently unsatisfactory.
• Anecdotal reports suggest potential for long-term disease-free survival following intensive treatment regimens.
• Chemotherapeutic regimens have demonstrated palliative response rates of up to 30%.

Conclusions:

• Malignant mesothelioma, despite its low incidence, poses significant diagnostic and therapeutic challenges.
• Early diagnosis and further research into intensive treatment strategies are crucial for improving patient outcomes.
• While palliative chemotherapy offers some benefit, achieving long-term remission remains a primary goal.